Association of PIN3 16-bp duplication polymorphism of TP53 with breast cancer risk in Mali and a meta-analysis.

Brehima DiakiteYaya KassogueGuimogo DoloOumar KassogueMamadou Lassine KeitaBrian JoyceErin NeuschlerJun WangJonah MusaCheick Bougari TraoreBakarou KamateEtienne DembeleSellama NadifiMercy IsicheiJane L HollRobert MurphySeydou DoumbiaLifang HouMamoudou Maiga

Published in: BMC medical genetics (2020)

The case-control study showed that PIN3 16-bp duplication polymorphism of TP53 is a significant risk factor for breast cancer in Malian women. These findings are supported by data from the meta-analysis carried out on different ethnic groups around the world.

Keyphrases

breast cancer risk
systematic review
meta analyses
electronic health record
big data
type diabetes
randomized controlled trial
metabolic syndrome